GU Cancers 2020 | Prostate active surveillance
VJOncology is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Jeff Tosoian, MD, MPH, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, discusses the use of active surveillance for the management of men with grade group 1 (GG1) prostate cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
Get great new content delivered to your inboxSign up